Loading clinical trials...
Loading clinical trials...
An International, Multicentre, Non-comparative, Non-interventional, Prospective Clinical Registry to Evaluate the Clinical Outcome and Safety of the Treatment of Severely Infected Patients with Fosfomycin I.v.
Conditions
Locations
50
Austria
Landeskrankenhaus Hall - Tirol Kliniken
Hall in Tirol, Austria
A.ö. Bezirkskrankenhaus
Reutte, Austria
AKH Wien, Universitätsklinik für Innere Medizin 1
Vienna, Austria
Klinikum Wels-Grieskirchen, Institut für Hygiene und Mikrobiologie
Wels, Austria
Universitätsmedizin Charité
Berlin, Germany
Vivantes Kliniken Neukölln
Berlin, Germany
Start Date
December 1, 2016
Primary Completion Date
December 1, 2030
Completion Date
December 1, 2030
Last Updated
October 1, 2024
NCT06704048
NCT04263792
NCT06135350
NCT06827496
NCT03594344
NCT06103500
Lead Sponsor
Infectopharm Arzneimittel GmbH
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions